• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人参皂苷 Rg1 治疗神经系统疾病的新方法及作用机制。

New Therapeutic Approaches to and Mechanisms of Ginsenoside Rg1 against Neurological Diseases.

机构信息

Hunan Engineering Technology Center of Standardization and Function of Chinese Herbal Decoction Pieces, College of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.

Pharmacy Department, Xiangtan Central Hospital, Xiangtan 411100, China.

出版信息

Cells. 2022 Aug 16;11(16):2529. doi: 10.3390/cells11162529.

DOI:10.3390/cells11162529
PMID:36010610
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9406801/
Abstract

Neurological diseases, including Parkinson's disease (PD), Alzheimer's disease (AD), Huntington's disease (HD), stroke, cerebral infarction, ischemia-reperfusion injury, depression and, stress, have high incidence and morbidity and often lead to disability. However, there is no particularly effective medication against them. Therefore, finding drugs with a suitable efficacy, low toxicity and manageable effects to improve the quality of life of patients is an urgent problem. Ginsenoside Rg1 (Rg1) is the main active component of ginseng and has a variety of pharmacological effects. In this review, we focused on the therapeutic potential of Rg1 for improving neurological diseases. We introduce the mechanisms of Ginsenoside Rg1 in neurological diseases, including apoptosis, neuroinflammation, the microRNA (miRNA) family, the mitogen-activated protein kinase (MAPK) family, oxidative stress, nuclear factor-κB (NF-κB), and learning and memory of Rg1 in neurological diseases. In addition, Rg1 can also improve neurological diseases through the interaction of different signal pathways. The purpose of this review is to explore more in-depth ideas for the clinical treatment of neurological diseases (including PD, AD, HD, stroke, cerebral infarction, ischemia-reperfusion injury, depression, and stress). Therefore, Rg1 is expected to become a new therapeutic method for the clinical treatment of neurological diseases.

摘要

神经系统疾病,包括帕金森病(PD)、阿尔茨海默病(AD)、亨廷顿病(HD)、中风、脑梗死、缺血再灌注损伤、抑郁和应激,具有较高的发病率和患病率,常导致残疾。然而,目前针对这些疾病并没有特别有效的药物。因此,寻找疗效适宜、毒性低、作用可调控的药物,以提高患者的生活质量,是一个亟待解决的问题。人参皂苷 Rg1(Rg1)是人参的主要活性成分,具有多种药理作用。在这篇综述中,我们重点介绍了 Rg1 改善神经系统疾病的治疗潜力。我们介绍了 Ginsenoside Rg1 在神经系统疾病中的作用机制,包括凋亡、神经炎症、微小 RNA(miRNA)家族、丝裂原活化蛋白激酶(MAPK)家族、氧化应激、核因子-κB(NF-κB)和 Rg1 对学习和记忆的影响。此外,Rg1 还可以通过不同信号通路的相互作用来改善神经系统疾病。本文的目的是探讨更多关于神经系统疾病(包括 PD、AD、HD、中风、脑梗死、缺血再灌注损伤、抑郁和应激)临床治疗的深入思路。因此,Rg1 有望成为治疗神经系统疾病的新方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ae/9406801/95d5621574cd/cells-11-02529-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ae/9406801/888d79e26a86/cells-11-02529-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ae/9406801/57b8554bbe7b/cells-11-02529-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ae/9406801/452f6a89bcad/cells-11-02529-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ae/9406801/a80ce3f7d4ac/cells-11-02529-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ae/9406801/3a7c6ce01058/cells-11-02529-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ae/9406801/a73a00f032e3/cells-11-02529-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ae/9406801/95d5621574cd/cells-11-02529-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ae/9406801/888d79e26a86/cells-11-02529-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ae/9406801/57b8554bbe7b/cells-11-02529-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ae/9406801/452f6a89bcad/cells-11-02529-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ae/9406801/a80ce3f7d4ac/cells-11-02529-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ae/9406801/3a7c6ce01058/cells-11-02529-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ae/9406801/a73a00f032e3/cells-11-02529-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ae/9406801/95d5621574cd/cells-11-02529-g007.jpg

相似文献

1
New Therapeutic Approaches to and Mechanisms of Ginsenoside Rg1 against Neurological Diseases.人参皂苷 Rg1 治疗神经系统疾病的新方法及作用机制。
Cells. 2022 Aug 16;11(16):2529. doi: 10.3390/cells11162529.
2
Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.黄芪和三七主要活性成分组合对脑缺血再灌注后神经细胞炎症和凋亡的影响
Am J Chin Med. 2015;43(7):1419-38. doi: 10.1142/S0192415X15500809. Epub 2015 Oct 18.
3
Ginsenoside Rg1 provides neuroprotection against blood brain barrier disruption and neurological injury in a rat model of cerebral ischemia/reperfusion through downregulation of aquaporin 4 expression.人参皂苷Rg1通过下调水通道蛋白4的表达,对大鼠脑缺血/再灌注模型中的血脑屏障破坏和神经损伤提供神经保护作用。
Phytomedicine. 2014 Jun 15;21(7):998-1003. doi: 10.1016/j.phymed.2013.12.005. Epub 2014 Jan 22.
4
Protective effect and mechanism of ginsenoside Rg1 in cerebral ischaemia-reperfusion injury in mice.人参皂苷 Rg1 对小鼠脑缺血再灌注损伤的保护作用及机制。
Biomed Pharmacother. 2018 Mar;99:876-882. doi: 10.1016/j.biopha.2018.01.136. Epub 2018 Feb 20.
5
Protective Effects and Target Network Analysis of Ginsenoside Rg1 in Cerebral Ischemia and Reperfusion Injury: A Comprehensive Overview of Experimental Studies.人参皂苷Rg1对脑缺血再灌注损伤的保护作用及靶点网络分析:实验研究综述
Cells. 2018 Dec 12;7(12):270. doi: 10.3390/cells7120270.
6
Ginsenoside Rg1 protects against hind-limb ischemia reperfusion induced lung injury via NF-κB/COX-2 signaling pathway.人参皂苷 Rg1 通过 NF-κB/COX-2 信号通路保护后肢缺血再灌注诱导的肺损伤。
Int Immunopharmacol. 2018 Jul;60:96-103. doi: 10.1016/j.intimp.2018.04.040. Epub 2018 Apr 27.
7
New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer's disease.人参皂苷 Rg1 在阿尔茨海默病治疗中的作用和机制的新认识。
Biomed Pharmacother. 2022 Aug;152:113207. doi: 10.1016/j.biopha.2022.113207. Epub 2022 Jun 3.
8
Ginsenoside Rg1, lights up the way for the potential prevention of Alzheimer's disease due to its therapeutic effects on the drug-controllable risk factors of Alzheimer's disease.人参皂苷 Rg1 通过对阿尔茨海默病可控的药物风险因素的治疗作用,为预防阿尔茨海默病提供了新的可能。
J Ethnopharmacol. 2024 Jan 10;318(Pt B):116955. doi: 10.1016/j.jep.2023.116955. Epub 2023 Aug 1.
9
Ginsenoside Rg1 protects mouse liver against ischemia-reperfusion injury through anti-inflammatory and anti-apoptosis properties.人参皂苷Rg1通过抗炎和抗凋亡特性保护小鼠肝脏免受缺血再灌注损伤。
J Surg Res. 2014 Sep;191(1):231-8. doi: 10.1016/j.jss.2014.03.067. Epub 2014 Mar 26.
10
Neuroprotective Effects of Ginsenosides against Cerebral Ischemia.人参皂苷对脑缺血的神经保护作用。
Molecules. 2019 Mar 20;24(6):1102. doi: 10.3390/molecules24061102.

引用本文的文献

1
Chronic lipopolysaccharide exposure promotes cognitive impairments by activating TRPC6-AIM2 inflammasome signaling and the regulation of ginsenoside Rg1 in Trpc6 mice.长期暴露于脂多糖通过激活TRPC6-AIM2炎性小体信号通路以及人参皂苷Rg1对Trpc6小鼠的调节作用来促进认知障碍。
Behav Brain Funct. 2025 Jul 22;21(1):23. doi: 10.1186/s12993-025-00290-1.
2
Ginsenoside Rg5 modulates the TLR4 and BCL-2 pathways by inhibiting NOX1, thereby alleviating inflammation, apoptosis and pyroptosis in hyperuricemia nephropathy.人参皂苷Rg5通过抑制NOX1调节TLR4和BCL-2信号通路,从而减轻高尿酸血症肾病中的炎症、凋亡和焦亡。
J Ginseng Res. 2025 Jul;49(4):426-437. doi: 10.1016/j.jgr.2025.03.009. Epub 2025 Mar 25.
3

本文引用的文献

1
Ginsenoside Rg1 improves Alzheimer's disease by regulating oxidative stress, apoptosis, and neuroinflammation through Wnt/GSK-3β/β-catenin signaling pathway.人参皂苷Rg1通过Wnt/GSK-3β/β-连环蛋白信号通路调节氧化应激、细胞凋亡和神经炎症,从而改善阿尔茨海默病。
Chem Biol Drug Des. 2022 Jun;99(6):884-896. doi: 10.1111/cbdd.14041. Epub 2022 Mar 31.
2
Ginsenoside Rg1 ameliorates blood-brain barrier disruption and traumatic brain injury attenuating macrophages derived exosomes miR-21 release.人参皂苷Rg1改善血脑屏障破坏和创伤性脑损伤,减少巨噬细胞衍生外泌体miR-21的释放。
Acta Pharm Sin B. 2021 Nov;11(11):3493-3507. doi: 10.1016/j.apsb.2021.03.032. Epub 2021 Mar 19.
3
Mechanism of Ginsenoside Rg in Regulating the Metabolic Function of Intestinal Flora for the Treatment of High-Purine Dietary Hyperuricemia.
人参皂苷Rg调节肠道菌群代谢功能治疗高嘌呤饮食性高尿酸血症的机制
Nutrients. 2025 May 28;17(11):1844. doi: 10.3390/nu17111844.
4
Ginsenoside Rg1 in Parkinson's disease: from basic research to clinical applications.人参皂苷Rg1在帕金森病中的应用:从基础研究到临床应用
Front Pharmacol. 2025 Apr 16;16:1490480. doi: 10.3389/fphar.2025.1490480. eCollection 2025.
5
Assessment of Pesticide Residues and Dietary Risks in Ginseng from Northeastern China.中国东北地区人参中农药残留及膳食风险评估
Foods. 2025 Apr 17;14(8):1381. doi: 10.3390/foods14081381.
6
A narrative review of : Unique saponins and their pharmacological activities.关于独特皂苷及其药理活性的叙述性综述。
J Ginseng Res. 2025 Mar;49(2):118-133. doi: 10.1016/j.jgr.2024.12.005. Epub 2024 Dec 20.
7
The spectrum-efficacy correlation of Kai-Xin-San for cognition of Aβ transgenic and verification of its active ingredients.开心散对Aβ转基因小鼠认知功能的谱效关系及其活性成分验证
Front Pharmacol. 2025 Jan 28;16:1538837. doi: 10.3389/fphar.2025.1538837. eCollection 2025.
8
Human disease-related long noncoding RNAs: Impact of ginsenosides.人类疾病相关的长链非编码RNA:人参皂苷的影响
J Ginseng Res. 2024 Jul;48(4):347-353. doi: 10.1016/j.jgr.2024.04.002. Epub 2024 Apr 14.
9
Ginsenoside Rg1 Regulates Immune Microenvironment and Neurological Recovery After Spinal Cord Injury Through MYCBP2 Delivery via Neuronal Cell-Derived Extracellular Vesicles.人参皂苷 Rg1 通过神经元细胞衍生的细胞外囊泡递送 MYCBP2 调节脊髓损伤后的免疫微环境和神经恢复。
Adv Sci (Weinh). 2024 Aug;11(31):e2402114. doi: 10.1002/advs.202402114. Epub 2024 Jun 19.
10
Ginsenosides for the treatment of insulin resistance and diabetes: Therapeutic perspectives and mechanistic insights.用于治疗胰岛素抵抗和糖尿病的人参皂苷:治疗前景与机制洞察
J Ginseng Res. 2024 May;48(3):276-285. doi: 10.1016/j.jgr.2024.03.002. Epub 2024 Mar 22.
Ginsenoside Rg1 Prevents Cognitive Impairment and Hippocampal Neuronal Apoptosis in Experimental Vascular Dementia Mice by Promoting GPR30 Expression.
人参皂苷 Rg1 通过促进 GPR30 表达来预防实验性血管性痴呆小鼠的认知障碍和海马神经元凋亡。
Neural Plast. 2021 Dec 3;2021:2412220. doi: 10.1155/2021/2412220. eCollection 2021.
4
Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment (Review).脑梗死和缺血性脑卒中的神经元损伤:从机制到治疗(综述)。
Int J Mol Med. 2022 Feb;49(2). doi: 10.3892/ijmm.2021.5070. Epub 2021 Dec 8.
5
Gisenoside Rg1 attenuates cadmium-induced neurotoxicity in vitro and in vivo by attenuating oxidative stress and inflammation.人参皂苷 Rg1 通过减轻氧化应激和炎症来减轻体外和体内镉诱导的神经毒性。
Inflamm Res. 2021 Dec;70(10-12):1151-1164. doi: 10.1007/s00011-021-01513-7. Epub 2021 Oct 18.
6
Ginsenoside Rg1 Ameliorates Neuroinflammation Suppression of Connexin43 Ubiquitination to Attenuate Depression.人参皂苷Rg1通过抑制连接蛋白43泛素化减轻神经炎症来缓解抑郁症。
Front Pharmacol. 2021 Aug 5;12:709019. doi: 10.3389/fphar.2021.709019. eCollection 2021.
7
The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance.肠脑轴与帕金森病:临床与发病机制相关性。
Ann Med. 2021 Dec;53(1):611-625. doi: 10.1080/07853890.2021.1890330.
8
Effect of ginsenoside-Rg1 on experimental Parkinson's disease: A systematic review and meta-analysis of animal studies.人参皂苷-Rg1对实验性帕金森病的影响:动物研究的系统评价与Meta分析
Exp Ther Med. 2021 Jun;21(6):552. doi: 10.3892/etm.2021.9984. Epub 2021 Mar 25.
9
Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer's disease.人参皂苷 Rg1 治疗阿尔茨海默病认知障碍的临床前系统评价。
Aging (Albany NY). 2021 Mar 3;13(5):7549-7569. doi: 10.18632/aging.202619.
10
Ginsenoside Rg1 improves cognitive capability and affects the microbiota of large intestine of tree shrew model for Alzheimer's disease.人参皂苷 Rg1 可改善认知能力,并影响阿尔茨海默病树鼩模型的大肠微生物群。
Mol Med Rep. 2021 Apr;23(4). doi: 10.3892/mmr.2021.11931. Epub 2021 Mar 2.